FRCP FRCPath - Scorpius Holdings Chief Board
| SCPX Stock | 0.33 0.03 8.33% |
Executive
FRCP FRCPath is Chief Board of Scorpius Holdings
| Address | 627 Davis Drive, Morrisville, NC, United States, 27560 |
| Phone | 919 240 7133 |
| Web | https://www.scorpiusbiologics.com |
Scorpius Holdings Management Efficiency
The company has return on total asset (ROA) of (0.3204) % which means that it has lost $0.3204 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9185) %, meaning that it created substantial loss on money invested by shareholders. Scorpius Holdings' management efficiency ratios could be used to measure how well Scorpius Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to decline to -0.93 this year. Return On Capital Employed is expected to decline to -1.08 this year. At this time, Scorpius Holdings' Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is expected to grow to about 2.3 M this year, although Total Assets will most likely decline.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Martin Goldberg | Seer Inc | N/A | |
| Bethany Cavanagh | Beam Therapeutics | N/A | |
| Allan MD | Prime Medicine, Common | 49 | |
| Pasit Phiasivongsa | Nurix Therapeutics | N/A | |
| Kathleen Borthwick | Passage Bio | 47 | |
| Asim Siddiqui | Seer Inc | N/A | |
| Karen JD | Prime Medicine, Common | N/A | |
| Karl Whitney | Passage Bio | N/A | |
| Kaitlin Duffy | Verve Therapeutics | N/A | |
| Cristiana Guiducci | Nurix Therapeutics | N/A | |
| Jason Kantor | Nurix Therapeutics | N/A | |
| Meredith Goldwasser | Prime Medicine, Common | 53 | |
| Manmohan Singh | Beam Therapeutics | N/A | |
| Eden Fucci | Passage Bio | N/A | |
| Sravan Emany | Beam Therapeutics | 46 | |
| JD Esq | Passage Bio | 60 | |
| David MD | Intellia Therapeutics | 69 | |
| Derek Hicks | Intellia Therapeutics | 50 | |
| Gopi Shanker | Beam Therapeutics | N/A | |
| Gregory Fuest | Passage Bio | N/A | |
| Nicole Esq | HCW Biologics | N/A | |
Management Performance
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.32 |
Scorpius Holdings Leadership Team
Elected by the shareholders, the Scorpius Holdings' board of directors comprises two types of representatives: Scorpius Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scorpius. The board's role is to monitor Scorpius Holdings' management team and ensure that shareholders' interests are well served. Scorpius Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scorpius Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey JD, Chairman, Founder | ||
| William Ostrander, Controller CFO | ||
| Abby Sorensen, Senior Manager | ||
| Nicole Temple, Senior Management | ||
| FRCP FRCPath, Chief Board | ||
| Peoples FACS, Chief Advisor | ||
| Ania Szymanska, Head Quality | ||
| Joe Payne, President BioManufacturing |
Scorpius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scorpius Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (11.45) % | ||||
| Current Valuation | 11.84 M | ||||
| Shares Outstanding | 4.87 M | ||||
| Shares Owned By Insiders | 7.57 % | ||||
| Shares Owned By Institutions | 19.08 % | ||||
| Number Of Shares Shorted | 99.57 K | ||||
| Price To Book | 0.06 X | ||||
| Price To Sales | 0.18 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Additional Tools for Scorpius Stock Analysis
When running Scorpius Holdings' price analysis, check to measure Scorpius Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scorpius Holdings is operating at the current time. Most of Scorpius Holdings' value examination focuses on studying past and present price action to predict the probability of Scorpius Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scorpius Holdings' price. Additionally, you may evaluate how the addition of Scorpius Holdings to your portfolios can decrease your overall portfolio volatility.